Greib A, Zhao S, Ploch M, Henricks J, Easterling R, Moodabagil M
Oncoimmunology. 2025; 14(1):2469375.
PMID: 39981683
PMC: 11849934.
DOI: 10.1080/2162402X.2025.2469375.
Lee D, Choi J, Choi S, Choi M, Hong M
Diagnostics (Basel). 2025; 15(3).
PMID: 39941243
PMC: 11817006.
DOI: 10.3390/diagnostics15030313.
Burns A, Steinberg A, Sargent J, Ozga J, Tang Z, Stanton C
Respir Res. 2025; 26(1):49.
PMID: 39920672
PMC: 11806618.
DOI: 10.1186/s12931-024-03087-4.
Raghavan D, Drummond K, Sanders S, Kirchner J
Chron Respir Dis. 2025; 22:14799731251314870.
PMID: 39911040
PMC: 11800250.
DOI: 10.1177/14799731251314870.
Zhou Y, Ampon M, Abramson M, James A, Maguire G, Wood-Baker R
Chron Respir Dis. 2025; 22:14799731241312687.
PMID: 39844530
PMC: 11755527.
DOI: 10.1177/14799731241312687.
CARABELA-COPD: A Novel Approach for the Transformation and Improvement of the Healthcare Process in COPD Management in Spain.
de Miguel-Diez J, Diez Manglano J, Mediavilla I, Escudero L
Open Respir Arch. 2025; 7(1):100387.
PMID: 39758956
PMC: 11696841.
DOI: 10.1016/j.opresp.2024.100387.
Machine learning-assisted construction of COPD self-evaluation questionnaire (COPD-EQ): a national multicentre study in China.
Ma Y, Zhan Z, Chen Y, Zhang J, Li W, He Z
J Glob Health. 2025; 15:04052.
PMID: 39749754
PMC: 11699521.
DOI: 10.7189/jogh.15.04052.
Factors associated with undiagnosed COPD in patients hospitalised for severe COPD exacerbation.
Guecamburu M, Klein E, Verdy G, Nocent-Ejnaini C, Macey J, Portel L
BMJ Open Respir Res. 2024; 11(1).
PMID: 39608870
PMC: 11603825.
DOI: 10.1136/bmjresp-2024-002620.
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools.
McFarlane M, Morra A, Lougheed M
Eur Respir Rev. 2024; 33(174).
PMID: 39603664
PMC: 11600127.
DOI: 10.1183/16000617.0247-2023.
Sex Differences in the Diagnosis of Chronic Obstructive Pulmonary Disease after Spirometry.
Moffett A, Halpern S, Weissman G
Ann Am Thorac Soc. 2024; 22(3):466-468.
PMID: 39589282
PMC: 11892671.
DOI: 10.1513/AnnalsATS.202404-402RL.
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement.
Wurzel D, Montgomery B, Anderson N, Schneider-Futschik E, George J, Bosnic-Anticevich S
Respirology. 2024; 30(2):101-112.
PMID: 39536776
PMC: 11788458.
DOI: 10.1111/resp.14852.
20-year trends in excess costs of COPD.
Amegadzie J, Mehareen J, Khakban A, Joshi P, Carlsten C, Sadatsafavi M
Eur Respir J. 2024; 65(1).
PMID: 39467610
PMC: 11780723.
DOI: 10.1183/13993003.00516-2024.
[Early diagnosis and treatment of chronic obstructive pulmonary disease and bronchial asthma].
Andermann T, Nitschmann S
Inn Med (Heidelb). 2024; 65(12):1293-1296.
PMID: 39365343
DOI: 10.1007/s00108-024-01787-z.
A Syndemic Model: COPD, Multimorbidity, and Poverty.
Hayes S, Bhatia-Lin A, Campbell J, Baugh A
Chronic Obstr Pulm Dis. 2024; 11(5):437-443.
PMID: 39326401
PMC: 11548973.
DOI: 10.15326/jcopdf.2024.0558.
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.
Solidoro P, Dente F, Micheletto C, Pappagallo G, Pelaia G, Papi A
Multidiscip Respir Med. 2024; 19.
PMID: 39291458
PMC: 11414512.
DOI: 10.5826/mrm.2024.949.
Rural Residence, Tobacco Use, and Nationwide Chronic Obstructive Pulmonary Disease Prevalence: Analyses from the National Health Interview Survey.
Raju S, Steinberg A, Ozga J, Sargent J, Tang Z, Stanton C
Ann Am Thorac Soc. 2024; 21(12):1774-1777.
PMID: 39269344
PMC: 11622818.
DOI: 10.1513/AnnalsATS.202311-973RL.
Artificial Intelligence in Chronic Obstructive Pulmonary Disease: Research Status, Trends, and Future Directions --A Bibliometric Analysis from 2009 to 2023.
Bian H, Zhu S, Zhang Y, Fei Q, Peng X, Jin Z
Int J Chron Obstruct Pulmon Dis. 2024; 19:1849-1864.
PMID: 39185394
PMC: 11345018.
DOI: 10.2147/COPD.S474402.
The Effect of a Post-Bronchodilator FEV/FVC < 0.7 on COPD Diagnosis and Treatment: A Regression Discontinuity Design.
Moffett A, Halpern S, Weissman G
medRxiv. 2024; .
PMID: 39148856
PMC: 11326314.
DOI: 10.1101/2024.08.05.24311519.
Global Insights into Chronic Obstructive Pulmonary Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis of 6,400,000 Patients.
Zheng Y, Hu Z, Seery S, Li C, Yang J, Wang W
Rev Cardiovasc Med. 2024; 25(1):25.
PMID: 39077650
PMC: 11262403.
DOI: 10.31083/j.rcm2501025.
Gender Differences in the Diagnosis of Chronic Obstructive Pulmonary Disease after Spirometry.
Moffett A, Halpern S, Weissman G
medRxiv. 2024; .
PMID: 39072031
PMC: 11275668.
DOI: 10.1101/2024.07.18.24310648.